Domestic Window Coverings Market size is valued at USD 27,539.3 million in 2021 and is expected to grow at a CAGR of 4.3% during the forecast period 2022 to 2028. Domestic Window Coverings is defined as the kind of technique that is used for recognizing numerous diseases found in poultry. The method includes chickens, ducks, waterfowl, turkeys, and other birds. Several diseases are seen in birds, such as Avian Mycoplasmosis, Avian Influenza, Infectious Bronchitis, Avian Salmonellosis, and others. The global market provides a detailed overview of the Domestic Window Coverings market size, and that can be segmented by type, by disease, and by Distribution channel. By type, the Domestic Window Coverings market growth has been segmented into PCR Test Kits, ELISA Test Kits, and Others. The Enzyme-Linked Immunosorbent Assay (Elisa) Tests segment is likely to be the largest and fastest-growing segment in terms of type. The rise of this segment is mainly due to the advantages it offers. This test provides greater specificity and sensitivity, cost-effectiveness, and precision. Based on Disease, the Domestic Window Coverings market is segmented into Bacterial diseases, Viral diseases, Parasitic diseases, Mycoses and Mycotoxicosis, and Neoplastic Diseases. Among these, the viral disease segment is expected to have the fastest-growing market during the forecast period 2022-2028. Domestic birds are usually infected by the low pathogenic kind producing respiratory diseases, failure in egg production, and clinical infections. In a few scenarios, high pathogenic (HPAI) forms may also contaminate domestic flocks. The high pathogenic type sources systemic infections and even mortality. Based on the Distribution channel, the Domestic Window Coverings market is segmented into Veterinary Hospitals, Veterinary Clinics, and Others. The Veterinary hospital’s segment is expected to have a significant share in 2021. The rise of this segment is mainly because it offers consultation, diagnostic testing, and extension services for backyard and commercial poultry drugs producers. These hospitals provide testing plans to cover one pet chicken, or minor flocks, or commercial producers.
In June 2022, Zoetis acquired Basepaws to expand Zoetis’ portfolio in animal health and pet care inventions.
In April 2022, BioChek acquired BIOTECON which offers complete diagnostic management solution.